In this handout picture released by the University of Oxford samples from coronavirus vaccine trials are dealt with inside the Oxford Vaccine Group lab in Oxford, England Thursday June 25, 2020.|Picture Credit:
AP.
.
.
Currently, phase 2 and 3 scientific trials of the Oxford vaccine prospect is going on in the UK, phase 3 scientific trial in Brazil and stage 1 and 2 clinical trials in South Africa.
Drugs Controller General of India has offered approval to Serum Institute of India (SII), Pune, to conduct Stage 2 and 3 medical trials of Oxford University-Astra Zeneca– COVID-19 vaccine (COVISHIELD) in India.
The permission was given late on Sunday after an assessment based upon the suggestions of the Subject Expert Committee on COVID-19, kept in mind a senior Health Ministry authorities.
Likewise read: Can a COVID-19 vaccine be established quickly?
” The company has to send security information, assessed by the Data Security Monitoring Board (DSMB), to the CDSCO prior to continuing to stage 3 medical trials,” a senior official said. “As per the research study style, each subject will be administered 2 doses four weeks apart (first dosage on da